Open original FDA record ↗Recall record
- FDA identifier
- Z-2327-2012
- Company in FDA record
- C.R. Bard, Inc., Urological Division
- FDA classification date
- Sep 7, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Incomplete seal on sterile packages of product.
Source facts
- Action
- C. R. Bard Inc, sent a Urgent Product Recall Notification letter dated June 27. 2012, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. This notification is being sent because there is a potential for a limited number of units within the subject lots (noted above) that may contain an open seal of the sterile packages. The issue is visually obvious even before the package is opened. No patient injury or adverse events have been reported. Do not use or further distribute any of the affected products. Once the product affected by tlle recall has been removed from your inventory 1.Fill out the Recall & Effectiveness Check Form. Be sure to state the quantities affected of the recalled product that you have in stock. It is extremely important that we receive this information. 2. Fax the Recall & Effectiveness Check Form to BMD at 1-770-784-6469. The Recall Coordinator will issue you with a Return Authorization (RCL) to facilitate the expedient return and replacement of the product. 3. A mailing label is enclosed for your convenience to return the affected product. Please mark the outside package as "RECALLED PRODUCT" and include the RCL number. All products should be retumed to the following shipping address that is in the letter.
- Initiated
- 2012-06-29
- Root cause
- Process control
- Terminated
- 2013-02-07
- Distribution
- Nationwide distribution: USA
- Recall number
- Z-2327-2012
- Recall status
- Terminated
- CDRH record ID
- 111691
- FDA classified
- 2012-09-07
- Recall event number
- 62774